United States Naltrexone HCL Market Report 2017

October 2017 | 100 pages | ID: U113D9CD222EN
QYResearch

Abstracts

In this report, the United States Naltrexone HCL market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Naltrexone HCL in these regions, from 2012 to 2022 (forecast).

United States Naltrexone HCL market competition by top manufacturers/players, with Naltrexone HCL sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Taj Pharmaceuticals
• Freedom Pharmaceuticals
• Rusan
• Sanofi
• IVAX
• Faran Shimi
• Sun Pharma
• Noramco
• Haida Taicheng

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Medical Grade
• Chemical Grade
• Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Naltrexone HCL for each application, including

• Opioid Independence
• Alcohol Independence
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Naltrexone HCL Market Report 2017

1 NALTREXONE HCL OVERVIEW

1.1 Product Overview and Scope of Naltrexone HCL
1.2 Classification of Naltrexone HCL by Product Category
  1.2.1 United States Naltrexone HCL Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Naltrexone HCL Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Medical Grade
  1.2.4 Chemical Grade
  1.2.5 Other
1.3 United States Naltrexone HCL Market by Application/End Users
  1.3.1 United States Naltrexone HCL Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Opioid Independence
  1.3.3 Alcohol Independence
  1.3.4 Other
1.4 United States Naltrexone HCL Market by Region
  1.4.1 United States Naltrexone HCL Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Naltrexone HCL Status and Prospect (2012-2022)
  1.4.3 Southwest Naltrexone HCL Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Naltrexone HCL Status and Prospect (2012-2022)
  1.4.5 New England Naltrexone HCL Status and Prospect (2012-2022)
  1.4.6 The South Naltrexone HCL Status and Prospect (2012-2022)
  1.4.7 The Midwest Naltrexone HCL Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Naltrexone HCL (2012-2022)
  1.5.1 United States Naltrexone HCL Sales and Growth Rate (2012-2022)
  1.5.2 United States Naltrexone HCL Revenue and Growth Rate (2012-2022)

2 UNITED STATES NALTREXONE HCL MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Naltrexone HCL Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Naltrexone HCL Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Naltrexone HCL Average Price by Players/Suppliers (2012-2017)
2.4 United States Naltrexone HCL Market Competitive Situation and Trends
  2.4.1 United States Naltrexone HCL Market Concentration Rate
  2.4.2 United States Naltrexone HCL Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Naltrexone HCL Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES NALTREXONE HCL SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Naltrexone HCL Sales and Market Share by Region (2012-2017)
3.2 United States Naltrexone HCL Revenue and Market Share by Region (2012-2017)
3.3 United States Naltrexone HCL Price by Region (2012-2017)

4 UNITED STATES NALTREXONE HCL SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Naltrexone HCL Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Naltrexone HCL Revenue and Market Share by Type (2012-2017)
4.3 United States Naltrexone HCL Price by Type (2012-2017)
4.4 United States Naltrexone HCL Sales Growth Rate by Type (2012-2017)

5 UNITED STATES NALTREXONE HCL SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Naltrexone HCL Sales and Market Share by Application (2012-2017)
5.2 United States Naltrexone HCL Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES NALTREXONE HCL PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Taj Pharmaceuticals
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Naltrexone HCL Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Taj Pharmaceuticals Naltrexone HCL Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Freedom Pharmaceuticals
  6.2.2 Naltrexone HCL Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Freedom Pharmaceuticals Naltrexone HCL Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Rusan
  6.3.2 Naltrexone HCL Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Rusan Naltrexone HCL Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Sanofi
  6.4.2 Naltrexone HCL Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Sanofi Naltrexone HCL Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 IVAX
  6.5.2 Naltrexone HCL Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 IVAX Naltrexone HCL Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Faran Shimi
  6.6.2 Naltrexone HCL Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Faran Shimi Naltrexone HCL Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Sun Pharma
  6.7.2 Naltrexone HCL Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Sun Pharma Naltrexone HCL Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Noramco
  6.8.2 Naltrexone HCL Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Noramco Naltrexone HCL Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Haida Taicheng
  6.9.2 Naltrexone HCL Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Haida Taicheng Naltrexone HCL Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview

7 NALTREXONE HCL MANUFACTURING COST ANALYSIS

7.1 Naltrexone HCL Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Naltrexone HCL

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Naltrexone HCL Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Naltrexone HCL Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES NALTREXONE HCL MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Naltrexone HCL Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Naltrexone HCL Sales Volume Forecast by Type (2017-2022)
11.3 United States Naltrexone HCL Sales Volume Forecast by Application (2017-2022)
11.4 United States Naltrexone HCL Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Naltrexone HCL
Figure United States Naltrexone HCL Market Size (K MT) by Type (2012-2022)
Figure United States Naltrexone HCL Sales Volume Market Share by Type (Product Category) in 2016
Figure Medical Grade Product Picture
Figure Chemical Grade Product Picture
Figure Other Product Picture
Figure United States Naltrexone HCL Market Size (K MT) by Application (2012-2022)
Figure United States Sales Market Share of Naltrexone HCL by Application in 2016
Figure Opioid Independence Examples
Table Key Downstream Customer in Opioid Independence
Figure Alcohol Independence Examples
Table Key Downstream Customer in Alcohol Independence
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Naltrexone HCL Market Size (Million USD) by Region (2012-2022)
Figure The West Naltrexone HCL Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Naltrexone HCL Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Naltrexone HCL Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Naltrexone HCL Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Naltrexone HCL Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Naltrexone HCL Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Naltrexone HCL Sales (K MT) and Growth Rate (2012-2022)
Figure United States Naltrexone HCL Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Naltrexone HCL Market Major Players Product Sales Volume (K MT) (2012-2017)
Table United States Naltrexone HCL Sales (K MT) of Key Players/Suppliers (2012-2017)
Table United States Naltrexone HCL Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Naltrexone HCL Sales Share by Players/Suppliers
Figure 2017 United States Naltrexone HCL Sales Share by Players/Suppliers
Figure United States Naltrexone HCL Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Naltrexone HCL Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Naltrexone HCL Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Naltrexone HCL Revenue Share by Players/Suppliers
Figure 2017 United States Naltrexone HCL Revenue Share by Players/Suppliers
Table United States Market Naltrexone HCL Average Price (USD/MT) of Key Players/Suppliers (2012-2017)
Figure United States Market Naltrexone HCL Average Price (USD/MT) of Key Players/Suppliers in 2016
Figure United States Naltrexone HCL Market Share of Top 3 Players/Suppliers
Figure United States Naltrexone HCL Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Naltrexone HCL Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Naltrexone HCL Product Category
Table United States Naltrexone HCL Sales (K MT) by Region (2012-2017)
Table United States Naltrexone HCL Sales Share by Region (2012-2017)
Figure United States Naltrexone HCL Sales Share by Region (2012-2017)
Figure United States Naltrexone HCL Sales Market Share by Region in 2016
Table United States Naltrexone HCL Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Naltrexone HCL Revenue Share by Region (2012-2017)
Figure United States Naltrexone HCL Revenue Market Share by Region (2012-2017)
Figure United States Naltrexone HCL Revenue Market Share by Region in 2016
Table United States Naltrexone HCL Price (USD/MT) by Region (2012-2017)
Table United States Naltrexone HCL Sales (K MT) by Type (2012-2017)
Table United States Naltrexone HCL Sales Share by Type (2012-2017)
Figure United States Naltrexone HCL Sales Share by Type (2012-2017)
Figure United States Naltrexone HCL Sales Market Share by Type in 2016
Table United States Naltrexone HCL Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Naltrexone HCL Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Naltrexone HCL by Type (2012-2017)
Figure Revenue Market Share of Naltrexone HCL by Type in 2016
Table United States Naltrexone HCL Price (USD/MT) by Types (2012-2017)
Figure United States Naltrexone HCL Sales Growth Rate by Type (2012-2017)
Table United States Naltrexone HCL Sales (K MT) by Application (2012-2017)
Table United States Naltrexone HCL Sales Market Share by Application (2012-2017)
Figure United States Naltrexone HCL Sales Market Share by Application (2012-2017)
Figure United States Naltrexone HCL Sales Market Share by Application in 2016
Table United States Naltrexone HCL Sales Growth Rate by Application (2012-2017)
Figure United States Naltrexone HCL Sales Growth Rate by Application (2012-2017)
Table Taj Pharmaceuticals Basic Information List
Table Taj Pharmaceuticals Naltrexone HCL Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Taj Pharmaceuticals Naltrexone HCL Sales Growth Rate (2012-2017)
Figure Taj Pharmaceuticals Naltrexone HCL Sales Market Share in United States (2012-2017)
Figure Taj Pharmaceuticals Naltrexone HCL Revenue Market Share in United States (2012-2017)
Table Freedom Pharmaceuticals Basic Information List
Table Freedom Pharmaceuticals Naltrexone HCL Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Freedom Pharmaceuticals Naltrexone HCL Sales Growth Rate (2012-2017)
Figure Freedom Pharmaceuticals Naltrexone HCL Sales Market Share in United States (2012-2017)
Figure Freedom Pharmaceuticals Naltrexone HCL Revenue Market Share in United States (2012-2017)
Table Rusan Basic Information List
Table Rusan Naltrexone HCL Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Rusan Naltrexone HCL Sales Growth Rate (2012-2017)
Figure Rusan Naltrexone HCL Sales Market Share in United States (2012-2017)
Figure Rusan Naltrexone HCL Revenue Market Share in United States (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Naltrexone HCL Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Sanofi Naltrexone HCL Sales Growth Rate (2012-2017)
Figure Sanofi Naltrexone HCL Sales Market Share in United States (2012-2017)
Figure Sanofi Naltrexone HCL Revenue Market Share in United States (2012-2017)
Table IVAX Basic Information List
Table IVAX Naltrexone HCL Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure IVAX Naltrexone HCL Sales Growth Rate (2012-2017)
Figure IVAX Naltrexone HCL Sales Market Share in United States (2012-2017)
Figure IVAX Naltrexone HCL Revenue Market Share in United States (2012-2017)
Table Faran Shimi Basic Information List
Table Faran Shimi Naltrexone HCL Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Faran Shimi Naltrexone HCL Sales Growth Rate (2012-2017)
Figure Faran Shimi Naltrexone HCL Sales Market Share in United States (2012-2017)
Figure Faran Shimi Naltrexone HCL Revenue Market Share in United States (2012-2017)
Table Sun Pharma Basic Information List
Table Sun Pharma Naltrexone HCL Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Sun Pharma Naltrexone HCL Sales Growth Rate (2012-2017)
Figure Sun Pharma Naltrexone HCL Sales Market Share in United States (2012-2017)
Figure Sun Pharma Naltrexone HCL Revenue Market Share in United States (2012-2017)
Table Noramco Basic Information List
Table Noramco Naltrexone HCL Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Noramco Naltrexone HCL Sales Growth Rate (2012-2017)
Figure Noramco Naltrexone HCL Sales Market Share in United States (2012-2017)
Figure Noramco Naltrexone HCL Revenue Market Share in United States (2012-2017)
Table Haida Taicheng Basic Information List
Table Haida Taicheng Naltrexone HCL Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Haida Taicheng Naltrexone HCL Sales Growth Rate (2012-2017)
Figure Haida Taicheng Naltrexone HCL Sales Market Share in United States (2012-2017)
Figure Haida Taicheng Naltrexone HCL Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Naltrexone HCL
Figure Manufacturing Process Analysis of Naltrexone HCL
Figure Naltrexone HCL Industrial Chain Analysis
Table Raw Materials Sources of Naltrexone HCL Major Players/Suppliers in 2016
Table Major Buyers of Naltrexone HCL
Table Distributors/Traders List
Figure United States Naltrexone HCL Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure United States Naltrexone HCL Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Naltrexone HCL Price (USD/MT) Trend Forecast (2017-2022)
Table United States Naltrexone HCL Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Naltrexone HCL Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Naltrexone HCL Sales Volume (K MT) Forecast by Type in 2022
Table United States Naltrexone HCL Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Naltrexone HCL Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Naltrexone HCL Sales Volume (K MT) Forecast by Application in 2022
Table United States Naltrexone HCL Sales Volume (K MT) Forecast by Region (2017-2022)
Table United States Naltrexone HCL Sales Volume Share Forecast by Region (2017-2022)
Figure United States Naltrexone HCL Sales Volume Share Forecast by Region (2017-2022)
Figure United States Naltrexone HCL Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources